Erick Forno1, Juan C Celedón. 1. Division of Pediatric Pulmonology, Department of Pediatrics, Miller School of Medicine, University of Miami, 1580 North West 10th Avenue, Miami, FL 33136, USA. eforno@med.miami.edu
Abstract
PURPOSE OF REVIEW: This review critically assesses recently published literature on predicting asthma exacerbations in children, while also providing general recommendations for future research in this field. RECENT FINDINGS: Current evidence suggests that every effort should be made to provide optimal treatment to achieve adequate asthma control, as this will significantly reduce the risk of severe disease exacerbations. Children who have had at least one asthma exacerbation in the previous year are at highest risk for subsequent exacerbations, regardless of disease severity and/or control. Although several tools and biomarkers to predict asthma exacerbations have been recently developed, these approaches need further validation and/or have only had partial success in identifying children at risk. SUMMARY: Although considerable progress has been made, much remains to be done. Future studies should clearly differentiate severe asthma exacerbations due to inadequate asthma control from those occurring in children whose asthma is well controlled, utilize standardized definitions of asthma exacerbations, and use a systematic approach to identify the best predictors after accounting for the multiple dimensions of the problem. Our ability to correctly predict the development of severe asthma exacerbations in an individual child should improve in parallel with increased knowledge and/or understanding of the complex interactions among genetic, environmental (e.g. viral infections) and lifestyle (e.g. adherence to treatment) factors underlying these events.
PURPOSE OF REVIEW: This review critically assesses recently published literature on predicting asthma exacerbations in children, while also providing general recommendations for future research in this field. RECENT FINDINGS: Current evidence suggests that every effort should be made to provide optimal treatment to achieve adequate asthma control, as this will significantly reduce the risk of severe disease exacerbations. Children who have had at least one asthma exacerbation in the previous year are at highest risk for subsequent exacerbations, regardless of disease severity and/or control. Although several tools and biomarkers to predict asthma exacerbations have been recently developed, these approaches need further validation and/or have only had partial success in identifying children at risk. SUMMARY: Although considerable progress has been made, much remains to be done. Future studies should clearly differentiate severe asthma exacerbations due to inadequate asthma control from those occurring in children whose asthma is well controlled, utilize standardized definitions of asthma exacerbations, and use a systematic approach to identify the best predictors after accounting for the multiple dimensions of the problem. Our ability to correctly predict the development of severe asthma exacerbations in an individual child should improve in parallel with increased knowledge and/or understanding of the complex interactions among genetic, environmental (e.g. viral infections) and lifestyle (e.g. adherence to treatment) factors underlying these events.
Authors: Ann Chen Wu; Kelan Tantisira; Lingling Li; Brooke Schuemann; Scott T Weiss; Anne L Fuhlbrigge Journal: Chest Date: 2011-02-03 Impact factor: 9.410
Authors: Samuel H Wedes; Weijia Wu; Suzy A A Comhair; Karen M McDowell; Joseph A DiDonato; Serpil C Erzurum; Stanley L Hazen Journal: J Pediatr Date: 2011-03-10 Impact factor: 4.406
Authors: John M Brehm; Juan C Celedón; Manuel E Soto-Quiros; Lydiana Avila; Gary M Hunninghake; Erick Forno; Daniel Laskey; Jody S Sylvia; Bruce W Hollis; Scott T Weiss; Augusto A Litonjua Journal: Am J Respir Crit Care Med Date: 2009-01-29 Impact factor: 21.405
Authors: Ngoc P Ly; Manuel E Soto-Quirós; Lydiana Avila; Gary M Hunninghake; Benjamin A Raby; Daniel Laskey; Jody S Sylvia; Juan C Celedón Journal: Chest Date: 2007-11-07 Impact factor: 9.410
Authors: Ronina A Covar; Stanley J Szefler; Robert S Zeiger; Christine A Sorkness; Mark Moss; David T Mauger; Susan J Boehmer; Robert C Strunk; Fernando D Martinez; Lynn M Taussig Journal: J Allergy Clin Immunol Date: 2008-10 Impact factor: 10.793
Authors: A Bossios; D Gourgiotis; C L Skevaki; P Saxoni-Papageorgiou; J Lötvall; S Psarras; T Karpathios; A G Constandopoulos; S L Johnston; N G Papadopoulos Journal: Clin Exp Allergy Date: 2008-07-18 Impact factor: 5.018
Authors: D R Taylor; E D Bateman; L-P Boulet; H A Boushey; W W Busse; T B Casale; P Chanez; P L Enright; P G Gibson; J C de Jongste; H A M Kerstjens; S C Lazarus; M L Levy; P M O'Byrne; M R Partridge; I D Pavord; M R Sears; P J Sterk; S W Stoloff; S J Szefler; S D Sullivan; M D Thomas; S E Wenzel; H K Reddel Journal: Eur Respir J Date: 2008-09 Impact factor: 16.671
Authors: Unnur S Bjornsdottir; Stephen T Holgate; Padmalatha S Reddy; Andrew A Hill; Charlotte M McKee; Cristina I Csimma; Amy A Weaver; Holly M Legault; Clayton G Small; Renee C Ramsey; Debra K Ellis; Conor M Burke; Philip J Thompson; Peter H Howarth; Andrew J Wardlaw; Phillip G Bardin; David I Bernstein; Louis B Irving; Geoffrey L Chupp; George W Bensch; Gregory W Bensch; Jon E Stahlman; Monroe Karetzky; James W Baker; Rachel L Miller; Brad H Goodman; Donald G Raible; Samuel J Goldman; Douglas K Miller; John L Ryan; Andrew J Dorner; Frederick W Immermann; Margot O'Toole Journal: PLoS One Date: 2011-07-14 Impact factor: 3.240
Authors: Nicholas C Newman; Patrick H Ryan; Bin Huang; Andrew F Beck; Hadley S Sauers; Robert S Kahn Journal: J Pediatr Date: 2014-03-27 Impact factor: 4.406
Authors: David B Kantor; Nicole Stenquist; Molly C McDonald; Blake J Schultz; Marissa Hauptman; Craig D Smallwood; Kyle A Nelson; Matthew S Perzanowski; Elizabeth C Matsui; Wanda Phipatanakul; Joel N Hirschhorn Journal: J Allergy Clin Immunol Date: 2016-06-15 Impact factor: 10.793